HTL0018318 + Placebo oral capsule
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety Issues
Conditions
Safety Issues, Pharmacokinetics
Trial Timeline
May 16, 2017 → Aug 20, 2017
NCT ID
NCT03198624About HTL0018318 + Placebo oral capsule
HTL0018318 + Placebo oral capsule is a phase 1 stage product being developed by Nxera Pharma for Safety Issues. The current trial status is completed. This product is registered under clinical trial identifier NCT03198624. Target conditions include Safety Issues, Pharmacokinetics.
What happened to similar drugs?
3 of 4 similar drugs in Safety Issues were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03198624 | Phase 1 | Completed |
Competing Products
20 competing products in Safety Issues